U.S Class(es): 005, 006, 018, 044, 046, 051, 052
Class Status: Active
| Name | Lori Wolfe Teva Pharmaceuticals USA, Inc. |
|---|---|
| Address | 400 Interpace Parkway Building A Parsippany, NJ 07054 United States |
| Date | Description | Action Tags | Code |
|---|---|---|---|
| Apr-09-2022 | NEW APPLICATION ENTERED | NWAPI | |
| Apr-11-2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
| Sep-20-2022 | ASSIGNED TO EXAMINER | DOCKD | |
| Sep-26-2022 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAP | |
| Oct-12-2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
| Nov-01-2022 | PUBLISHED FOR OPPOSITION | PUBOA | |
| Nov-01-2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
| Nov-21-2022 | EXTENSION OF TIME TO OPPOSE RECEIVED | ETOFT | |
| Dec-15-2022 | TEAS PETITION TO AMEND BASIS RECEIVED | TPADI | |
| Dec-15-2022 | POST PUBLICATION AMENDMENT RECEIVED | PPARI | |
| Jan-10-2023 | ASSIGNED TO PETITION STAFF | APETA | |
| Jan-11-2023 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | ETOPT | |
| Jan-13-2023 | POST PUBLICATION AMENDMENT - ENTERED | CHPBI | |
| Feb-28-2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | NOAME | |
| Aug-16-2023 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
| Aug-16-2023 | SOU EXTENSION 1 FILED | EXT1S | |
| Aug-16-2023 | SOU EXTENSION 1 GRANTED | EX1GS | |
| Aug-18-2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
| Feb-27-2024 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
| Feb-27-2024 | SOU EXTENSION 2 FILED | EXT2S | |
| Feb-27-2024 | SOU EXTENSION 2 GRANTED | EX2GS | |
| Feb-28-2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
| Aug-19-2024 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
| Aug-19-2024 | SOU EXTENSION 3 FILED | EXT3S | |
| Aug-19-2024 | SOU EXTENSION 3 GRANTED | EX3GS | |
| Aug-19-2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
| Jan-22-2025 | SOU TEAS EXTENSION RECEIVED | EEXTI | |
| Jan-22-2025 | SOU EXTENSION 4 FILED | EXT4S | |
| Jan-22-2025 | SOU EXTENSION 4 GRANTED | EX4GS | |
| Mar-04-2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
| Sep-29-2025 | ABANDONMENT - NO USE STATEMENT FILED | ABN6S | |
| Sep-29-2025 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | MAB6E | |
| Sep-30-2025 | TEAS PETITION TO REVIVE RECEIVED | PROAI | |
| Sep-30-2025 | PETITION TO REVIVE-GRANTED | PETGO | |
| Sep-30-2025 | NOTICE OF REVIVAL - E-MAILED | NREVE | |
| Sep-30-2025 | SOU EXTENSION RECEIVED WITH TEAS PETITION | TPEXI | |
| Nov-12-2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL | AITUA | |
| Aug-27-2025 | SOU EXTENSION 5 FILED | EXT5S | |
| Nov-13-2025 | SOU EXTENSION 5 GRANTED | EX5GS | |
| Nov-14-2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
| Feb-10-2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | REAPI | |
| Feb-10-2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | ARAAI | |
| Feb-10-2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | TCCAI | |
| Mar-30-2026 | ABANDONMENT - NO USE STATEMENT FILED | ABN6S | |
| Mar-30-2026 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | MAB6E |